[Federal Register Volume 88, Number 207 (Friday, October 27, 2023)]
[Notices]
[Pages 73881-73882]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23793]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2023-0101]


Information Collection: NRC Form 483, Registration Certificate--
In Vitro Testing With Byproduct Material Under General License

AGENCY: Nuclear Regulatory Commission.

ACTION: Renewal of existing information collection; request for 
comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public 
comment on the renewal of Office of Management and Budget (OMB) 
approval for an existing collection of information. The information 
collection is entitled, NRC Form 483, ``Registration Certificate--In 
Vitro Testing with Byproduct Material Under General License.''

DATES: Submit comments by December 26, 2023. Comments received after 
this date will be considered if it is practical to do so, but the 
Commission is able to ensure consideration only for comments received 
on or before this date.

ADDRESSES: You may submit comments by any of the following methods; 
however, the NRC encourages electronic comment submission through the 
Federal rulemaking website:
    <bullet> Federal rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2023-0101. Address 
questions about Docket IDs in Regulations.gov to Stacy Schumann; 
telephone: 301-415-0624; email: <a href="/cdn-cgi/l/email-protection#bae9cedbd9c394e9d9d2cfd7dbd4d4fad4c8d994ddd5cc"><span class="__cf_email__" data-cfemail="e4b79085879dcab7878c9189858a8aa48a9687ca838b92">[email protected]</span></a>. For technical 
questions, contact the individual listed in the For Further Information 
Contact section of this document.
    <bullet> Mail comments to: David C. Cullison, Office of the Chief 
Information Officer, Mail Stop: T-6 A10M, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: David C. Cullison, Office of the Chief 
Information Officer, U.S. Nuclear Regulatory Commission, Washington,

[[Page 73882]]

DC 20555-0001; telephone: 301-415-2084; email: 
<a href="/cdn-cgi/l/email-protection#175e79717874787b7b727463643945726478626574725779657439707861"><span class="__cf_email__" data-cfemail="a4edcac2cbc7cbc8c8c1c7d0d78af6c1d7cbd1d6c7c1e4cad6c78ac3cbd2">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2023-0101 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly available information related to this action by any of the 
following methods:
    <bullet> Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2023-0101. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC-2023-0101 on this website.
    <bullet> NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, at 301-415-4737, 
or by email to <a href="/cdn-cgi/l/email-protection#bbebffe995e9dec8d4cec9d8defbd5c9d895dcd4cd"><span class="__cf_email__" data-cfemail="7e2e3a2c502c1b0d110b0c1d1b3e100c1d50191108">[email protected]</span></a>. A copy of the collection of 
information and related instructions may be obtained without charge by 
accessing ADAMS Accession No. ML23214A355. The supporting statement is 
available in ADAMS under Accession No. ML23214A375.
    <bullet> NRC's PDR: The PDR, where you may examine and order copies 
of publicly available documents, is open by appointment. To make an 
appointment to visit the PDR, please send an email to 
<a href="/cdn-cgi/l/email-protection#80d0c4d2aed2e5f3eff5f2e3e5c0eef2e3aee7eff6"><span class="__cf_email__" data-cfemail="623226304c3007110d17100107220c10014c050d14">[email protected]</span></a> or call 1-800-397-4209 or 301-415-4737, between 8 
a.m. and 4 p.m. eastern time (ET), Monday through Friday, except 
Federal holidays.
    <bullet> NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, David C. Cullison, Office of 
the Chief Information Officer, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-2084; email: 
<a href="/cdn-cgi/l/email-protection#a1e8cfc7cec2cecdcdc4c2d5d28ff3c4d2ced4d3c2c4e1cfd3c28fc6ced7"><span class="__cf_email__" data-cfemail="cc85a2aaa3afa3a0a0a9afb8bfe29ea9bfa3b9beafa98ca2beafe2aba3ba">[email protected]</span></a>.

B. Submitting Comments

    The NRC encourages electronic comment submission through the 
Federal rulemaking website (https://www.regulations.gov). Please 
include Docket ID NRC-2023-0101, in your comment submission.
    The NRC cautions you not to include identifying or contact 
information in comment submissions that you do not want to be publicly 
disclosed in your comment submission. All comment submissions are 
posted at https://www.regulations.gov and entered into ADAMS. Comment 
submissions are not routinely edited to remove identifying or contact 
information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that comment submissions are not routinely edited to remove such 
information before making the comment submissions available to the 
public or entering the comment into ADAMS.

II. Background

    In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 
Chapter 35), the NRC is requesting public comment on its intention to 
request the OMB's approval for the information collection summarized 
below.
    1. The title of the information collection: NRC Form 483, 
Registration Certificate--In Vitro Testing with Byproduct Material 
Under General License.
    2. OMB approval number: 3150-0038.
    3. Type of submission: Extension.
    4. The form number, if applicable: NRC Form 483.
    5. How often the collection is required or requested: There is a 
one-time submittal of information to receive a validated copy of the 
NRC Form 483 with an assigned registration number. In addition, any 
changes in the information reported on the NRC Form 483 must be 
reported in writing to the NRC within 30 days after the effective date 
of the change.
    6. Who will be required or asked to respond: Any physician, 
veterinarian in the practice of veterinary medicine, clinical 
laboratory, or hospital which desires a general license to receive, 
acquire, possess, transfer, or use specified units of byproduct 
material in certain in vitro clinical or laboratory tests.
    7. The estimated number of annual responses: 3.
    8. The estimated number of annual respondents: 3.
    9. The estimated number of hours needed annually to comply with the 
information collection requirement or request: 0.51 hours annually, (3 
registrations/year using NRC Form 483 x 0.17 hrs. per NRC Form 483 = 
0.51 hrs.).
    10. Abstract: Section 31.11 of title 10 of the Code of Federal 
Regulations (10 CFR), established a general license authorizing any 
physician, clinical laboratory, veterinarian in the practice of 
veterinary medicine, or hospital to possess certain small quantities of 
byproduct material for in vitro clinical or laboratory tests not 
involving the internal or external administration of the byproduct 
material or the radiation therefrom to human beings or animals. 
Possession of byproduct material under 10 CFR 31.11 is not authorized 
until the physician, clinical laboratory, veterinarian in the practice 
of veterinary medicine, or hospital has filed the NRC Form 483 and 
received from the Commission a validated copy of the NRC Form 483 with 
a registration number. The licensee can use the validated copy of the 
NRC Form 483 to obtain byproduct material from a specifically licensed 
supplier. The NRC incorporates this information into a database which 
is used to verify that a general licensee is authorized to receive the 
byproduct material.

III. Specific Requests for Comments

    The NRC is seeking comments that address the following questions:
    1. Is the proposed collection of information necessary for the NRC 
to properly perform its functions? Does the information have practical 
utility? Please explain your answer.
    2. Is the estimate of the burden of the information collection 
accurate? Please explain your answer.
    3. Is there a way to enhance the quality, utility, and clarity of 
the information to be collected?
    4. How can the burden of the information collection on respondents 
be minimized, including the use of automated collection techniques or 
other forms of information technology?

    Dated: October 24, 2023.

    For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2023-23793 Filed 10-26-23; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>